Ataxin 2 (ATXN2) (Middle Region) Peptide
ATXN2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Ataxin 2 (ATXN2) products
- Ataxin 2 (ATXN2)
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ATXN2 antibody (Catalog #: ARP38210_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Ataxin 2 (ATXN2)
- Background
-
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA ty
Alias Symbols: ATX2, FLJ46772, SCA2, TNRC13
Protein Interaction Partner: A2BP1,ACTN1,ACTN2,ATXN1,BAT3,BIN1,CHGB,GFI1B,IDH3B,KIAA1279,LCP1,NCOA4,PABPC1,PLS3,SH3GL2,SH3GL3,TDRD7,ZNRD1,CD247,CHGB,VHL
Protein Size: 1313 - Molecular Weight
- 140 kDa
- Gene ID
- 6311
- NCBI Accession
- NM_002973, NP_002964
- UniProt
- Q99700
-
You are here:
